Vishay Precision Group, Inc. (NYSE:VPG ) Q4 2024 Earnings Conference Call February 12, 2025 9:00 AM ET Company Participants Steven Cantor - Senior Director of Investor Relations Ziv Shoshani - Chief Executive Officer and President William Clancy - Executive Vice President and Chief Financial Officer Conference Call Participants John Franzreb - Sidoti & Company Griffin Boss - B. Riley Securities Operator Good morning, everyone, and welcome to the VPG Fourth Quarter Fiscal 2024 Earnings Call.

Lesaka Technologies shares have entered another slump, after performing strongly during early-to-late 2024. While on the surface the South Africa-based fintech delivered mixed results, a closer look suggests that Lesaka is successfully executing its growth strategy. Based on updates to guidance, signs that Lesaka could continue to execute strongly, coupled with other factors at play, shares remain poised for an eventual breakout to $10 per share.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Capri Holdings Limited (NYSE:CPRI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capri-holdings-lawsuit-submission-form?prid=129157&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=129158&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=129159&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129160&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=129161&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129163&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=129162&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129156&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK and BERLIN, Feb. 12, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders, today announced the pricing of a registered underwritten offering of 26,190,477 common shares, at a price of $2.10 per share. atai has granted the underwriter a 30-day option to purchase up to an additional 3,928,571 common shares. All common shares to be sold in the offering will be sold by atai.

AtriCure, Inc. (NASDAQ:ATRC ) Q4 2024 Earnings Conference Call February 12, 2025 4:30 PM ET Company Participants Marissa Bych - Investor Relations Michael Carrel - President and Chief Executive Officer Angela Wirick - Chief Financial Officer Conference Call Participants Lily Lozada - JPMorgan William Plovanic - Canaccord Matthew O'Brien - Piper Sandler Marie Thibault - BTIG Rick Wise - Stifel Mike Matson - Needham & Company Danny Stauder - Citizens JMP Danielle Antalffy - UBS Suraj Kalia - Oppenheimer Matthew O'Brien - Piper Sandler Operator Good afternoon, and welcome to AtriCure's Fourth Quarter and Full Year 2024 Earnings Conference Call. …

LEAWOOD, Kan., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Euronet (or the “Company”) (NASDAQ: EEFT), a global leader in payments processing and cross-border transactions, today announced fourth quarter and full year 2024 financial results.

Reddit CEO Steve Huffman said the site saw "volatility" in traffic in Q4 due to Google's algorithm change. The impact shows how some users still rely on an external search engine to get answers from Reddit.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against ICON plc (the “Company”) (NasdaqGS: ICLR), if they purchased the Company's shares between July 27, 2023 and October 23, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 31, 2025 to file lead plaintiff applications in a securities class action lawsuit against Integral Ad Science Holding Corp. (the “Company”) (NasdaqGS: IAS), if they purchased the Company's shares between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 24, 2025 to file lead plaintiff applications in a securities class action lawsuit against Crocs, Inc. (NasdaqGS: CROX), if they purchased the Company's shares between November 3, 2022, and October 28 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Delaware.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 24, 2025 to file lead plaintiff applications in securities class action lawsuits against Transocean Ltd. (the “Company”) (NYSE: RIG), if they purchased the Company's securities between May 1, 2023 and September 2, 2024, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Southern District of New York.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against Innovative Industrial Properties, Inc. (NYSE: IIPR), if they purchased the Company's securities between February 27, 2024 and December 19, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Maryland.

NEW ORLEANS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 14, 2025 to file lead plaintiff applications in a securities class action lawsuit against Pacira BioSciences, Inc. (the “Company”) (NasdaqGS: PCRX), if they purchased the Company's securities between August 2, 2023 and August 8, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.